Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000351108 | SCV000357931 | uncertain significance | Disorders of Intracellular Cobalamin Metabolism | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000190394 | SCV001017859 | likely benign | Cobalamin C disease | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000190394 | SCV001527836 | uncertain significance | Cobalamin C disease | 2018-10-11 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Pars Genome Lab | RCV000190394 | SCV001652880 | uncertain significance | Cobalamin C disease | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000190394 | SCV004237854 | likely benign | Cobalamin C disease | 2022-12-13 | criteria provided, single submitter | clinical testing | |
Inserm U 954, |
RCV000190394 | SCV000243928 | not provided | Cobalamin C disease | no assertion provided | not provided | ||
Prevention |
RCV004755801 | SCV005350599 | likely benign | MMACHC-related disorder | 2024-07-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |